Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$152K Sell
10,400
-12,000
-54% -$176K ﹤0.01% 10378
2025
Q4
$283K Buy
22,400
+11,900
+113% +$176K ﹤0.01% 8968
2025
Q3
$161K Buy
10,500
+200
+2% +$3.22K ﹤0.01% 9833
2025
Q2
$162K Hold
10,300
﹤0.01% 8691
2025
Q1
$197K Buy
+10,300
New +$225K ﹤0.01% 8465
2024
Q4
Sell
-15,300
Closed -$428K 10411
2024
Q3
$428K Sell
15,300
-800
-5% -$22.6K ﹤0.01% 7465
2024
Q2
$421K Sell
16,100
-3,200
-17% -$66.6K ﹤0.01% 7295
2024
Q1
$422K Buy
+19,300
New +$414K ﹤0.01% 6978
2023
Q3
Sell
-30,100
Closed -$682K 9275
2023
Q2
$682K Buy
+30,100
New +$606K ﹤0.01% 5835
2023
Q1
Sell
-284,200
Closed -$4.83M 9799
2022
Q4
$4.83M Buy
+284,200
New +$5.04M ﹤0.01% 2535

Other funds holding RXO

Jane Street's RXO Position: Q1 2026 in Review

Jane Street sold out of RXO (RXO) in Q1 2026, closing a stake of 310,254 shares — an estimated $4.55M sold.

Jane Street first reported a position in RXO in Q4 2022 and held it in 10 quarters. The position peaked at $9.42M in Q3 2024. 275 funds tracked by Wall St. Rank hold RXO as of Q1 2026.

  • Jane Street reported no remaining RXO position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 310,254 RXO shares in Q1 2026, an estimated $4.55M.
  • Jane Street first reported a position in RXO in Q4 2022 and held it in 10 quarters.
  • Jane Street's RXO position peaked at $9.42M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held RXO as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.